+

WO2018190677A3 - Method for purifying analogous antibody using cation-exchange chromatography - Google Patents

Method for purifying analogous antibody using cation-exchange chromatography Download PDF

Info

Publication number
WO2018190677A3
WO2018190677A3 PCT/KR2018/004345 KR2018004345W WO2018190677A3 WO 2018190677 A3 WO2018190677 A3 WO 2018190677A3 KR 2018004345 W KR2018004345 W KR 2018004345W WO 2018190677 A3 WO2018190677 A3 WO 2018190677A3
Authority
WO
WIPO (PCT)
Prior art keywords
cation
exchange chromatography
purifying
analogous
analogous antibody
Prior art date
Application number
PCT/KR2018/004345
Other languages
French (fr)
Other versions
WO2018190677A2 (en
Inventor
Sung-Muk KANG
Hong Jai Lee
Kyunghwa Kim
Jung Min Yoo
Chung Min Lee
Gyung-Hwa LEE
Dong Eok Lee
Sung In Lim
Gyong-sik HA
Original Assignee
Cj Healthcare Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Healthcare Corporation filed Critical Cj Healthcare Corporation
Publication of WO2018190677A2 publication Critical patent/WO2018190677A2/en
Publication of WO2018190677A3 publication Critical patent/WO2018190677A3/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/522—CH1 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present disclosure relates to a method for separating impurities of analogous antibodies using cation-exchange chromatography, and more specifically, to a method for separating the single fragments and isoforms of analogous antibodies, which are produced during the process of producing analogous antibodies, and purifying only target antibody fragments in high purity and yield using an elution buffer for the cation-exchange chromatography.
PCT/KR2018/004345 2017-04-14 2018-04-13 Method for purifying analogous antibody using cation-exchange chromatography WO2018190677A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20170048635 2017-04-14
KR10-2017-0048635 2017-04-14

Publications (2)

Publication Number Publication Date
WO2018190677A2 WO2018190677A2 (en) 2018-10-18
WO2018190677A3 true WO2018190677A3 (en) 2019-01-17

Family

ID=63792713

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/004345 WO2018190677A2 (en) 2017-04-14 2018-04-13 Method for purifying analogous antibody using cation-exchange chromatography

Country Status (4)

Country Link
KR (1) KR102140693B1 (en)
AR (1) AR111465A1 (en)
TW (1) TWI679209B (en)
WO (1) WO2018190677A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102209790B1 (en) * 2018-12-20 2021-02-01 에이치케이이노엔 주식회사 Method for purification of vaccine virus using affinity chromatography
CN110066314B (en) * 2019-04-01 2023-10-27 上海药明生物技术有限公司 Affinity purification process for efficiently improving separation resolution of multimer
CN114539417A (en) * 2020-11-26 2022-05-27 盛禾(中国)生物制药有限公司 Chromatographic purification process for effectively removing bispecific antibody homodimers

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130136883A (en) * 2012-06-05 2013-12-13 씨제이제일제당 (주) A novel method for purifying long-acting human growth hormone
KR20140142974A (en) * 2013-06-05 2014-12-15 한화케미칼 주식회사 A Method of Antibody Purification
US20150056196A1 (en) * 2007-10-30 2015-02-26 Genentech, Inc. Antibody purification by cation exchange chromatography
US20160264618A1 (en) * 2013-10-30 2016-09-15 Celltrion Inc. Method for separating antibody isoforms using cation exchange chromatography
US20170066814A1 (en) * 2010-12-21 2017-03-09 Hoffmann-La Roche Inc. Isoform enriched antibody preparation and method for obtaining it

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170136649A (en) * 2009-10-20 2017-12-11 애브비 인코포레이티드 Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150056196A1 (en) * 2007-10-30 2015-02-26 Genentech, Inc. Antibody purification by cation exchange chromatography
US20170066814A1 (en) * 2010-12-21 2017-03-09 Hoffmann-La Roche Inc. Isoform enriched antibody preparation and method for obtaining it
KR20130136883A (en) * 2012-06-05 2013-12-13 씨제이제일제당 (주) A novel method for purifying long-acting human growth hormone
KR20140142974A (en) * 2013-06-05 2014-12-15 한화케미칼 주식회사 A Method of Antibody Purification
US20160264618A1 (en) * 2013-10-30 2016-09-15 Celltrion Inc. Method for separating antibody isoforms using cation exchange chromatography

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LEE, HONG JAI ET AL.: "Purification of antibody fragments for the reduction of charge variants using cation exchange chromatography", JOURNAL OF CHROMATOGRAPHY B, vol. 1080, 31 January 2018 (2018-01-31), pages 20 - 26, XP055566960 *

Also Published As

Publication number Publication date
AR111465A1 (en) 2019-07-17
KR102140693B1 (en) 2020-08-05
TW201841933A (en) 2018-12-01
KR20180116159A (en) 2018-10-24
WO2018190677A2 (en) 2018-10-18
TWI679209B (en) 2019-12-11

Similar Documents

Publication Publication Date Title
WO2018190677A3 (en) Method for purifying analogous antibody using cation-exchange chromatography
WO2013177115A3 (en) Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography
WO2014149387A8 (en) Solid phase peptide synthesis processes and associated systems
MX2019000082A (en) Tagatose 6-phosphoric acid-specific novel heat-resistant phosphatase, and method for preparing tagatose by using same.
WO2014178078A3 (en) Novel cloning, expression & purification method for the preparation of ranibizumab
WO2018105934A3 (en) Method for efficient production of psicose
MX2020000288A (en) Chromatography.
HRP20240146T1 (en) Methods of making and using pde9 inhibitors
MX342235B (en) Optimized method for antibody capturing by mixed mode chromatography.
WO2018236184A3 (en) Method for producing d-psicose from d-psicose borate complex using chromatography and composition containing d-psicose
EA202191502A1 (en) METHOD FOR PRODUCING APIXABAN
WO2020069050A3 (en) Methods of treating neurodegenerative diseases
MX2016013416A (en) Novel purification process of gonadotropin.
MX2015012249A (en) Method to produce cis 1-chloro-3,3,3-trifluoropropene.
MX2015014193A (en) Method for separating and purifying recombined human lactoferrin from rice seeds.
MX361536B (en) Method for synthesising ambroxide from ageratina jocotepecana.
WO2016084100A3 (en) Novel and efficient method for large scale synthesis of romidepsin
EA201792655A1 (en) METHOD OF SYNTHESIS 9,9-BIS (HYDROXYMETHyl) FLUORENE
MX2021015087A (en) METHODS TO REMOVE UNWANTED COMPONENTS DURING MULTI-STAGE CHROMATOGRAPHIC PROCESSES.
WO2023081935A3 (en) Self-amplifying rna compositions and methods of use thereof
PH12021551008A1 (en) Purification method for vaccine virus using affinity chromatography
MY189781A (en) Method for preparing polythiols
IL284402A (en) Process for producing, isolating, and purifying modified recombinant proteins
MX2022005965A (en) Novel multispecific antibody format.
MX2019013750A (en) A method for producing refolded recombinant humanized ranibizumab.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18784972

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18784972

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载